Noveris Health Sciences is trading 10% down now at CA$0.09, with the decline appearing consistent with broader risk-off trading.

  • Shares reached CA$0.10 on September 22, 2026; trading activity details were unavailable.
  • Major U.S. indexes were lower, while rising crude oil and Treasury yields pressured equity valuations.
  • No new company-specific announcement was identified for September 23; the latest confirmed CSE release remains the September 9 annual and special meeting results.